Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation:Results of a phase I study

Stem Cells Translational Medicine

Volumn 2, Issue 2, 2013, Pages 107-111

  Reinders, Marlies E J ^a   de Fijter, Johan W ^a   Roelofs, Helene ^a   Bajema, Ingeborg M ^a   de Vries, Dorottya K ^a   Schaapherder, Alexander F ^a   Claas, Frans H J ^a   van Miert, Paula P M C ^a   Roelen, Dave L ^a   van Kooten, Cees ^a   Fibbe, Willem E ^a   Rabelink, Ton J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunosuppression; Kidney; Mesenchymal stem cells; Transplantation

Indexed keywords

BASILIXIMAB; CD45 ANTIGEN; CYCLOSPORIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; ATROPHY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BK VIRUS INFECTION; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; FOLLOW UP; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MESENCHYMAL STROMA CELL; MIXED LYMPHOCYTE REACTION; PHASE 1 CLINICAL TRIAL; PROPHYLAXIS;

EID: 84876510229     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0114     Document Type: Article

References (18)

1. Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346:580-590.
2. Tolar J, Le Blanc K, Keating A et al. Concise review: Hitting the right spot with mesenchymal stromal cells. STEM CELLS 2010; 28:1446-1455.
3. Franquesa M, Herrero E, Torras J et al. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev 2012; 21:3125-3135.
4. Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006; 70:121-129.
5. Morigi M, Introna M, Imberti B et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. STEM CELLS 2008; 26:2075-2082.
6. Casiraghi F, Azzollini N, Todeschini M et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am J Transplant 2012; 12:2373-2383.
7. Inoue S, Popp FC, Koehl GE et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 2006; 81:1589-1595.
8. Ge W, Jiang J, Baroja ML et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009; 9:1760-1772.
9. English K, French A, Wood KJ. Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell 2010; 7:431-442.
10. Salem HK, Thiemermann C. Mesenchymal stromal cells: Current understanding and clinical status. STEM CELLS 2010; 28:585-596.
11. Hoogduijn MJ, Popp FC, Grohnert A et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation 2010; 90:124-126.
12. Reinders ME, Fibbe WE, Rabelink TJ. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 2010; 25:17-24.
13. Tan J, Wu W, Xu X et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial. JAMA 2012; 307:1169-1177.
14. Perico N, Casiraghi F, Introna M et al. Autologous mesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol 2011; 6:412-422.
15. Roos-van Groningen MC, Scholten EM, Lelieveld PM et al. Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies. J Am Soc Nephrol 2006; 17:881-888.
16. Solez K, Colvin RB, Racusen LC et al. Banff'05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN). Am J Transplant 2007; 7:518-526.
17. Duijvestein M, Vos AC, Roelofs H et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: Results of a phase I study. Gut 2010; 59:1662-1669.
18. Lashley LE, van der Hoorn ML, van der Mast BJ et al. Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus. Hum Immunol 2011; 72: 805-811.